Washington, DC 9/17/14—In a filing with the SEC, VWR has set an IPO price of $22–$25 per share (see IBO 6/30/14) and will offer 25,532,000 shares of common stock on the NASDAQ stock exchange. At the midpoint of the price range, the company expects to raise approximately $561.0 million. Following the offering, current majority-owners Madison […]
Darmstadt, Germany and St. Louis, MO 9/22/14—Pharmaceutical and chemical company Merck KGaA has agreed to acquire Sigma-Aldrich, a life science and technology firm, for $140 per share in cash, or approximately $17 billion. The price represents a 37% premium to Sigma’s September 19 closing stock price. The companies offer a complementary range of products including […]
Merck KGaA became the latest company to enlarge its stake in the laboratory-products market with its announcement on September 22 of an agreement to purchase Sigma-Aldrich for approximately €13.1 billion ($17 billion = €0.77 = $1) in cash (see page 2). Together, the firms will create a €4.7 billion ($6.1 billion) supplier of laboratory and […]
Company Announcements For the first six months, sales for Mettler-Toledo‘s Laboratory business grew 6% excluding currency to roughly $533 million to account for 46% of revenues. First and second quarter Laboratory sales advanced 7% and 6% excluding currency, respectively. Sales growth was driven by increased demand and favorable pricing for analytical instruments and laboratory balances. […]
Second quarter IBO Life Science Index sales grew 5.1%, 6.0% excluding currency, to $3,568 million. Operating profit jumped 11.2% to $780 million. Illumina’s strong financial performance accounted for roughly half of the Index’s organic sales and operating profit growth. Based on continuing operations, operating margin advanced 100 basis points to 19.6% of sales. Sequenom was […]
London, UK 9/9/14; Cambridge, UK 9/9/14—Abcam, a publicly held provider of protein-research tools and services, announced the appointment of Alan Hirzel as CEO, effective immediately. He replaces Jonathan Milner, PhD, who will now serve as deputy chairman. Mr. Hirzel previously served as chief marketing officer. “Alan will take over the leadership of the company, with […]
San Diego, CA 9/2/14—BioLegend acquired on August 29 the Antibody Services business unit of Covance for an undisclosed amount. The business develops and manufactures antibodies and research reagents for neuroscience, immunopathology, cell biology, epitope tags and immunohistochemistry detection, including IVD antibodies for immunohistochemistry (IHC). “The addition of Neuroscience and IHC antibody tools to our catalog […]
Yokohama, Japan 9/9/14—Publicly held Japanese iPSC firm ReproCELL has acquired the iPS Cell Business Unit of Stemgent for an undisclosed amount. The Business Unit supplies iPSC-research reagent products, including mRNA reprogramming kits, xeno-free culture media and specialty chemicals for cell differentiation. ReproCELL stated that the acquisition would broaden its selection of iPSC products and strengthen […]
Radnor, PA 9/10/14—VWR has acquired Netherlands- and Belgium-based Klinipath and its affiliates Immunologic, Mortupath and Klinipath BVBA for an undisclosed amount. Kilinipath provides equipment, consumables and reagents, representing suppliers for the histology, pathology, cytology, immunology and clinical chemistry industries, as well as supplies private-label equipment, reagents and plastic disposables. “Klinipath, Immunologic and Mortupath are recognized […]
The US economy showed further gains in August as second quarter GDP growth was revised from 4.0% to 4.2%, led by consumer spending and inventory surges. However, while growth was stronger than expected following a slow start to the year due to extreme weather conditions, housing prices showed signs of slowing, and labor markets were […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
